FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Teva Pharmaceuticals PARICALCITOL Capsules Recall

PARICALCITOL Capsules, 4 mcg, 30-count bottles, Rx only, Manufactured By: Pharmaceutics…

Teva Pharmaceuticals USA · North Wales, PA

Risk level
Class III
Reported by FDA
Oct 26, 2016
Recall ID
D-0111-2017
Check your lot numberHow we source this data

Summary

Teva Pharmaceuticals recalled PARICALCITOL Capsules starting Sep 22, 2016. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0111-2017 on Oct 26, 2016. Reason: Failed Impurities/Degradation Specifications: out of specification test results for impurities during stability testing. Status: Terminated.

Why it was recalled

Failed Impurities/Degradation Specifications: out of specification test results for impurities during stability testing.

Product description

PARICALCITOL Capsules, 4 mcg, 30-count bottles, Rx only, Manufactured By: Pharmaceutics International, Inc., Hunt Vallet, MD 21031; Manufactured For: Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 0093-7658-56.

Lot numbers, UPCs & expiration codes

Lot #: 13010.006A, Exp 09/16; 13010.007A, Exp 05/17

Where it was sold

Nationwide and Puerto Rico

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0111-2017
Classification
Class III
Status
Terminated
Recall initiated
Sep 22, 2016
FDA report date
Oct 26, 2016
Quantity
5,398 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Teva Pharmaceuticals USA

Original FDA data

Every field from FDA enforcement report D-0111-2017, exactly as published.

Show all FDA fields
City
North Wales
State
PA
Status
Terminated
Country
United States
Event ID
75300
Address
1090 Horsham Rd
Code information
Lot #: 13010.006A, Exp 09/16; 13010.007A, Exp 05/17
Postal code
19454-1505
Report date
Oct 26, 2016
Product type
Drugs
Recall number
D-0111-2017
Classification
Class III
Recalling firm
Teva Pharmaceuticals USA
Product quantity
5,398 bottles
Termination date
May 5, 2017
Reason for recall
Failed Impurities/Degradation Specifications: out of specification test results for impurities during stability testing.
Voluntary / mandated
Voluntary: Firm initiated
Product description
PARICALCITOL Capsules, 4 mcg, 30-count bottles, Rx only, Manufactured By: Pharmaceutics International, Inc., Hunt Vallet, MD 21031; Manufactured For: Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 0093-7658-56.
Distribution pattern
Nationwide and Puerto Rico
Recall initiation date
Sep 22, 2016
Initial firm notification
Letter
Center classification date
Oct 19, 2016

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0111-2017, published Oct 26, 2016. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls